Matrix-embedded cells control osteoclast formation

被引：0
作者：
Jinhu Xiong
Melda Onal
Robert L Jilka
Robert S Weinstein
Stavros C Manolagas
Charles A O'Brien
机构：
[1] Center for Osteoporosis and Metabolic Bone Diseases,
[2] University of Arkansas for Medical Sciences (UAMS),undefined
[3] Central Arkansas Veterans Healthcare System,undefined
来源：
Nature Medicine | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
To date, the dogma in the field has been that RANKL, an essential cytokine in osteoclast maturation, is released by osteoblasts as a way to coordinate bone growth and bone loss during adult bone remodeling. Now, Hiroshi Takayanagi and colleagues, as well as Charles O'Brien and colleagues, have independently found that osteocytes are the predominant source of RANKL in the adult mouse. As RANKL signaling is a key target in treating osteoporosis, these results have potentially important implications for disease management.
引用
收藏
页码：1235 / 1241
页数：6
相关论文
共 73 条
[31]  
Jilka RL(2001)Receptor activator of NF-κB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis J. Biol. Chem. 276 20659-20672
[32]  
Parfitt AM(1999)Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature 402 304-309
[33]  
Manolagas SC(1998)Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc. Natl. Acad. Sci. USA 95 3597-3602
[34]  
Weinstein RS(1999)STAT3 activation in stromal osteoblastic cells is required for induction of the receptor activator of NF-κB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D-3 or parathyroid hormone J. Biol. Chem. 274 19301-19308
[35]  
Logan M(2009)Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL J. Bone Miner. Res. 24 182-195
[36]  
Dougall WC(2007)Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction Cell Metab. 5 464-475
[37]  
Rodda SJ(1998)Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 165-176
[38]  
McMahon AP(2011)The amazing osteocyte J. Bone Miner. Res. 26 229-238
[39]  
Kobayashi T(2001)A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy Bone 28 145-149
[40]  
Zhang M(2003)“Whither flows the fluid in bone?” An osteocyte's perspective J. Biomech. 36 1409-1424
12345678